News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
291,921 Results
Type
Article (15667)
Company Profile (299)
Press Release (275949)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (81718)
Career Advice (179)
Deals (13626)
Drug Delivery (40)
Drug Development (52314)
Employer Resources (35)
FDA (6390)
Job Trends (5552)
News (149627)
Policy (10592)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (970)
Accelerated approval (19)
Adcomms (14)
Allergies (84)
Alliances (22188)
ALS (124)
Alzheimer's disease (1061)
Antibody-drug conjugate (ADC) (248)
Approvals (6605)
Artificial intelligence (266)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4962)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (230)
Bladder cancer (115)
Brain cancer (45)
Breast cancer (366)
Cancer (3231)
Cardiovascular disease (242)
Career advice (162)
Career pathing (7)
CAR-T (218)
CDC (5)
Cell therapy (566)
Cervical cancer (18)
Clinical research (45219)
Collaboration (1163)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1152)
CRISPR (87)
C-suite (553)
Cystic fibrosis (114)
Data (4454)
Denatured (15)
Depression (93)
Diabetes (258)
Diagnostics (1486)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (191)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (32889)
Editorial (25)
Employer branding (5)
Employer resources (32)
Events (52698)
Executive appointments (627)
FDA (8230)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (986)
Gene editing (183)
Generative AI (22)
Gene therapy (487)
GLP-1 (514)
Government (1214)
Grass and pollen (3)
Guidances (190)
Healthcare (6966)
HIV (26)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (40)
Indications (70)
Infectious disease (1262)
Inflammatory bowel disease (161)
Inflation Reduction Act (10)
Influenza (39)
Intellectual property (171)
Interviews (20)
IPO (7512)
IRA (12)
Job creations (881)
Job search strategy (139)
JPM (40)
Kidney cancer (9)
Labor market (23)
Layoffs (248)
Leadership (10)
Legal (1449)
Liver cancer (43)
Longevity (11)
Lung cancer (437)
Lymphoma (251)
Machine learning (25)
Management (8)
Manufacturing (378)
MASH (130)
Medical device (3098)
Medtech (3108)
Mergers & acquisitions (6746)
Metabolic disorders (737)
Multiple sclerosis (104)
NASH (14)
Neurodegenerative disease (233)
Neuropsychiatric disorders (71)
Neuroscience (1988)
Neurotech (1)
NextGen: Class of 2026 (2109)
Non-profit (910)
Now hiring (30)
Obesity (337)
Opinion (129)
Ovarian cancer (134)
Pain (108)
Pancreatic cancer (163)
Parkinson's disease (233)
Partnered (12)
Patents (310)
Patient recruitment (336)
Peanut (44)
People (26901)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15688)
Phase 2 (20834)
Phase 3 (13577)
Pipeline (3339)
Policy (91)
Postmarket research (986)
Preclinical (6587)
Press Release (31)
Prostate cancer (148)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (656)
Real estate (1479)
Recruiting (14)
Regulatory (10378)
Reports (19)
Research institute (1014)
Resumes & cover letters (21)
Rett syndrome (24)
RNA editing (21)
RSV (18)
Schizophrenia (123)
Series A (184)
Series B (137)
Service/supplier (1)
Sickle cell disease (80)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (17)
Startups (2034)
State (1)
Stomach cancer (5)
Supply chain (33)
Tariffs (18)
The Weekly (62)
Vaccines (356)
Venture capital (69)
Weight loss (179)
Women's health (29)
Worklife (3)
Date
Today (6)
Last 7 days (354)
Last 30 days (1311)
Last 365 days (18298)
2026 (1681)
2025 (18565)
2024 (21070)
2023 (23028)
2022 (27670)
2021 (28682)
2020 (24162)
2019 (17002)
2018 (12401)
2017 (14358)
2016 (12424)
2015 (14906)
2014 (10792)
2013 (7795)
2012 (7842)
2011 (7990)
2010 (7759)
Location
Africa (165)
Alabama (65)
Alaska (2)
Arizona (72)
Arkansas (5)
Asia (18820)
Australia (3195)
California (7213)
Canada (1874)
China (787)
Colorado (251)
Connecticut (261)
Delaware (261)
Europe (40353)
Florida (943)
Georgia (214)
Hawaii (2)
Idaho (19)
Illinois (404)
India (35)
Indiana (178)
Iowa (8)
Japan (236)
Kansas (81)
Kentucky (10)
Louisiana (7)
Maine (11)
Maryland (752)
Massachusetts (5653)
Michigan (112)
Minnesota (260)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (25)
New Jersey (1758)
New Mexico (13)
New York (1782)
North Carolina (831)
North Dakota (6)
Northern California (3549)
Ohio (183)
Oklahoma (11)
Oregon (24)
Pennsylvania (1300)
Puerto Rico (9)
Rhode Island (25)
South America (225)
South Carolina (9)
Southern California (2849)
Tennessee (45)
Texas (954)
United States (23925)
Utah (98)
Virginia (137)
Washington D.C. (37)
Washington State (612)
West Virginia (1)
Wisconsin (48)
291,921 Results for "frequency therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
December 8, 2025
·
6 min read
Press Releases
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder
December 8, 2025
·
16 min read
Deals
Korro Bio and Frequency Therapeutics Announce Merger Agreement
Korro Bio, Inc. and Frequency Therapeutics, Inc. announced that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction.
July 14, 2023
·
18 min read
Lone Star Bio
Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System
Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 11,872,397 relating to the Company’s non-invasive, frequency-based deep brain stimulation device.
January 23, 2024
·
4 min read
Deals
Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million
Korro Bio, Inc. announced the completion of the previously announced business combination between Frequency Therapeutics, Inc. and the entity formerly known as Korro Bio, Inc.
November 3, 2023
·
9 min read
Deals
UPDATE: Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million
Korro Bio, Inc. announced the completion of the previously announced business combination between Frequency Therapeutics, Inc. and the entity formerly known as Korro Bio, Inc.
November 3, 2023
·
9 min read
Press Releases
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
December 23, 2025
·
6 min read
Press Releases
BiaCure Therapies Awarded SBIR Phase II Grant to Advance Development of High-Frequency Energy Technology for the Treatment of Onychomycosis
May 16, 2025
·
2 min read
Press Releases
BiaCure Therapies Awarded SBIR Phase I Grant to Advance Development of High-Frequency Energy Technology for the Treatment of Onychomycosis
May 15, 2025
·
2 min read
1 of 29,193
Next
